Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

German researchers say the answer may be in virus-reactive memory T cells, which are triggered by COVID infection.

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

The Wistar Institute's Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...

Chinese University of Hong Kong researchers find patients with cancer-associated EBV DNA in blood have 87-fold increased risk ...

The Epstein-Barr virus (EBV) is one of the most common human viruses worldwide. According to the Centers for Disease Control and Prevention (CDC), EBV can | Immunology ...

An expert discusses strategies for monitoring response to treatment, including observation, Epstein-Barr virus (EBV) titers, ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly ...

Chinese University of Hong Kong researchers find patients with cancer-associated EBV DNA in blood have 87-fold increased risk ...